Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?

Publicado en línea: 28 sept 2019

Páginas: 154 - 159

Recibido: 08 ene 2019

Aceptado: 27 mar 2019

DOI: https://doi.org/10.2478/cipms-2019-0028

Palabras clave

ovarian cancer, peritoneal carcinomatosis, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, p53, BRCA 1

© 2019 Roman Yarema et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.